Skip to content

Risk stratification of lymph node metastasis in T2 colorectal cancer

Risk stratification of lymph node metastasis in T2 colorectal cancer - Risk stratification of lymph node metastasis in T2 colorectal cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000050534
Enrollment
600
Registered
2023-03-09
Start date
2022-07-21
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Interventions

None listed

Sponsors

Showa University Northern Yokohama Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: T2 colorectal cancer resected surgically

Exclusion criteria

Exclusion criteria: Patients with (1) familial adenomatous polyposis, (2) Lynch syndrome, (3) inflammatory bowel disease, (4) invasion to deeper than muscularis propria in surgical specimens, (5) preoperative chemotherapy or radiotherapy (6) lesions without lymph node dissection.

Design outcomes

Primary

MeasureTime frame
Sensitivity and AUC for the presence of lymph node metastasis

Countries

Japan,Asia(except Japan),Europe

Contacts

Public ContactKatsuro Ichimasa

Showa University Northern Yokohama Hospital Digestive Disease Center

ichimasa@nus.edu.sg+81459497535

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026